Role of vaccination and adoptive immune transfer in persistent hepatitis B virus infection

Indian Journal of Gastroenterology

Volumn 20, Issue SUPPL. 1, 2001, Pages

  Shouval, D ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADJUVANT THERAPY; ANTIMICROBIAL THERAPY; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; CONFERENCE PAPER; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; PERSISTENT VIRUS INFECTION; TREATMENT OUTCOME; VACCINATION;

BONE MARROW TRANSPLANTATION; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; IMMUNOTHERAPY, ADOPTIVE; VIRAL ENVELOPE PROTEINS;

EID: 0035085963     PISSN: 02548860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Hepatitis B virus immunopathogenesis
2. Specific vaccine therapy in chronic hepatitis B: Induction of T cell proliferative responses specific for envelope antigens
3. Immunotherapy of chronic hepatitis B in Asian patients using a novel triple antigen hepatitis B vaccine (Hepacare)
4. Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from HBV immune donors
5. Adoptive transfer of immunity to hepatitis B in humans following T-depleted bone marrow transplantation from HBV immune donors
6. Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors
7. Transplantation of hepatitis B immune lymphocytes as means for adoptive transfer of immunity to HBV
8. Adoptive transfer of immunity to hepatitis B: Development of the concept and evolution of the research project for targeted immunotherapy against hepatic cells which express a viral antigen
9. Ablation of persistent hepatitis B by allogeneic bone marrow transplantation from an HBV immune donor
10. Clearance of hepatitis B surface antigen after bone marrow transplantation: Role of adoptive immunity transfer
11. Clearance of persistent hepatitis B virus infection in Chinese bone marrow transplant recipients whose donors were anti-hepatitis B core and anti-hepatitis B surface antibody-positive
12. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients
13. Hepatitis viruses and hematopoietic cell transplantation: A guide to patient and donor management
14. Development of a pre-S1, pre-S2 and S recombinant hepatitis B vaccine in mammalian cells
15. Safety, tolerability and immunogenicity in adults and children of a mammalian cell-derived recombinant hepatitis B vaccine containing S, pre-S1 and pre-S2
16. Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines
17. Immunogenicity of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S2 and pre-S1 antigens: A preliminary report
18. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens in children
19. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens in neonates
20. Reactogenicity and immunogenicity of a new recombinant hepatitis B vaccine containing pre S antigens: A preliminary report
21. Recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein - A preliminary study on immunogenicity
22. Comparison of immunogenicity of a pre-S containing HBV vaccine with non-pre-S containing vaccines
23. Rapid seroprotection against hepatitis B following the first dose of pre-S1/pre-S2/S vaccine